Mobilizing the proteolytic machine: Cell biological roles of proteasome activators and inhibitors

Trends in Cell Biology

Volumn 15, Issue 1, 2005, Pages 27-33

  Rechsteiner, Martin ^a   Hill, Christopher P ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; ENZYME ACTIVATOR; PROTEASOME ACTIVATOR; PROTEASOME ACTIVATOR 200; PROTEASOME ACTIVATOR 28; PROTEASOME INHIBITOR; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ALPHA CHAIN; ANTIGEN PRESENTATION; APOPTOSIS; BETA CHAIN; CELLULAR IMMUNITY; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; CYTOTOXIC T LYMPHOCYTE; DNA REPLICATION; EUKARYOTIC CELL; FIBROBLAST; GENETIC CODE; HUMAN; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SEQUENCE ANALYSIS; STRUCTURAL HOMOLOGY; STRUCTURE ANALYSIS; TRYPANOSOMA BRUCEI;

ANIMALS; APOPTOSIS; AUTOANTIGENS; ENZYME ACTIVATION; HUMANS; IMMUNE SYSTEM; MUSCLE PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX;

EUKARYOTA; TRYPANOSOMA; TRYPANOSOMA BRUCEI;

EID: 11844287006     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcb.2004.11.003     Document Type: Review

References (64)

1. A. Ciechanover Ubiquitin-mediated proteolysis: biological regulation via destruction Bioessays 22 2000 442 451
2. J. Löwe Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 Å resolution Science 268 1995 533 539
3. M. Groll Structure of 20S proteasome from yeast at 2.4Å resolution Nature 386 1997 463 471
4. M. Groll A gated channel into the proteasome core particle Nat. Struct. Biol. 7 2000 1062 1067
5. D. Voges The 26S proteasome: a molecular machine designed for controlled proteolysis Annu. Rev. Biochem. 68 1999 1015 1068
6. C.P. Hill The 11S regulators of 20S proteasome activity Curr. Top. Microbiol. Immunol. 268 2002 73 89
7. V. Ustrell PA200, a nuclear proteasome activator involved in DNA repair EMBO J. 21 2002 3516 3525
8. F.G. Whitby Structural basis for the activation of 20S proteasomes by 11S regulators Nature 408 2000 115 120
9. A. Forster The pore of activated 20S proteasomes has an ordered 7-fold symmetric conformation EMBO J. 22 2003 4356 4364
10. J. Li Lysine 188 substitutions convert the pattern of proteasome activation by REGγ to that of REGs α and β EMBO J. 20 2001 3359 3369
11. N. Tanahashi Hybrid proteasomes. Induction by interferon-γ and contribution to ATP-dependent proteolysis J. Biol. Chem. 275 2000 14336 14345
12. A.V. Kajava New HEAT-like repeat motifs in proteins regulating proteasome structure and function J. Struct. Biol. 146 2004 425 430
13. P. Masson Identification and characterization of a Drosophila nuclear proteasome regulator. A homolog of human 11 S REGγ (PA28γ) J. Biol. Chem. 276 2001 1383 1390
14. S. Khan Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver J. Immunol. 167 2001 6859 6868
15. C. Watts The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules Nat. Immunol. 5 2004 685 692
16. J.W. Yewdell Making sense of mass destruction: quantitating MHC class I antigen presentation Nat. Rev. Immunol. 3 2003 952 961
17. M. Rechsteiner The proteasome activator 11 S REG (PA28) and class I antigen presentation Biochem. J. 345 2000 1 15
18. T. Preckel Impaired immunoproteasome assembly and immune responses in PA28-/- mice Science 286 1999 2162 2165
19. S. Murata Immunoproteasome assembly and antigen presentation in mice lacking both PA28α and PA28β EMBO J. 20 2001 5898 5907
20. K. Schwarz The proteasome regulator PA28α/β can enhance antigen presentation without affecting 20S proteasome subunit composition Eur. J. Immunol. 30 2000 3672 3679
21. J. Li Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturation Int. Immunol. 13 2001 1515 1523
22. T. Yamano Two distinct pathways mediated by PA28 and hsp90 in major histocompatibility complex class I antigen processing J. Exp. Med. 196 2002 185 196
23. A.F. Kisselev The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation J. Biol. Chem. 274 1999 3363 3371
24. P. Cascio Properties of the hybrid form of the 26S proteasome containing both 19S and PA28 complexes EMBO J. 21 2002 2636 2645
25. G.A. Ordway Chronic contractile activity upregulates the proteasome system in rabbit skeletal muscle J. Appl. Physiol. 88 2000 1134 1141
26. G. Fuertes Changes in the proteolytic activities of proteasomes and lysosomes in human fibroblasts produced by serum withdrawal, amino-acid deprivation and confluent conditions Biochem. J. 375 2003 75 86
27. P. Gromov Protein profiling of the human epidermis from the elderly reveals up-regulation of a signature of interferon-{γ}-induced polypeptides that includes manganese-superoxide dismutase and the p85{β} subunit of phosphatidylinositol 3-kinase Mol. Cell. Proteomics 2 2003 70 84
28. Y. Minami A critical role for the proteasome activator PA28 in the Hsp90-dependent protein refolding J. Biol. Chem. 275 2000 9055 9061
29. S. Murata Growth retardation in mice lacking the proteasome activator PA28γ J. Biol. Chem. 274 1999 38211 38215
30. L.F. Barton Immune defects in 28-kDa proteasome activator γ-deficient mice J. Immunol. 172 2004 3948 3954
31. P. Masson Drosophila proteasome regulator REGγ: transcriptional activation by DNA replication-related factor DREF and evidence for a role in cell cycle progression J. Mol. Biol. 327 2003 1001 1012
32. T. Nikaido Loss in transformed cells of cell cycle regulation of expression of a nuclear protein recognized by SLE patient antisera Exp. Cell Res. 182 1989 284 289
33. C. Hagemann MEKK3 interacts with the PA28 γ regulatory subunit of the proteasome Biochem. J. 373 2003 71 79
34. R.J. Davis Signal transduction by the JNK group of MAP kinases Cell 103 2000 239 252
35. Y. Imai The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis Nature 398 1999 777 785
36. X. Yang Daxx, a novel Fas-binding protein that activates JNK and apoptosis Cell 89 1997 1067 1076
37. L.Y. Chen, and J.D. Chen Daxx silencing sensitizes cells to multiple apoptotic pathways Mol. Cell. Biol. 23 2003 7108 7121
38. D. Bai RanBPM is a novel binding protein for p75NTR Biochem. Biophys. Res. Commun. 309 2003 552 557
39. B. Liu, and K. Shuai Induction of apoptosis by protein inhibitor of activated Stat1 through c-Jun NH2-terminal kinase activation J. Biol. Chem. 276 2001 36624 36631
40. T. Okamura Abnormally high expression of proteasome activator-γ in thyroid neoplasm J. Clin. Endocrinol. Metab. 88 2003 1374 1383
41. J.R. Lipford, and R.J. Deshaies Diverse roles for ubiquitin-dependent proteolysis in transcriptional activation Nat. Cell Biol. 5 2003 845 850
42. D. Obradovic DAXX, FLASH, and FAF-1 modulate mineralocorticoid and glucocorticoid receptor-mediated transcription in hippocampal cells - toward a basis for the opposite actions elicited by two nuclear receptors? Mol. Pharmacol. 65 2004 761 769
43. K. Moriishi Proteasome activator PA28γ-dependent nuclear retention and degradation of hepatitis C virus core protein J. Virol. 77 2003 10237 10249
44. M. Aouida A genome-wide screen in Saccharomyces cerevisiae reveals altered transport as a mechanism of resistance to the anticancer drug bleomycin Cancer Res. 64 2004 1102 1109
45. M. Fehlker Blm3 is part of nascent proteasomes and is involved in a late stage of nuclear proteasome assembly EMBO Rep. 4 2003 959 963
46. S.H. Lecker Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression FASEB J. 18 2004 39 51
47. J. Adams The proteasome: a suitable antineoplastic target Nat. Rev. Cancer 4 2004 349 360
48. T. Goasduff, and A.I. Cederbaum CYP2E1 degradation by in vitro reconstituted systems: role of the molecular chaperone hsp90 Arch. Biochem. Biophys. 379 2000 321 330
49. X. Lu Heat shock protein-90 and the catalytic activities of the 20 S proteasome (multicatalytic proteinase complex) Arch. Biochem. Biophys. 387 2001 163 171
50. S.L. McCutchen-Maloney cDNA cloning, expression, and functional characterization of PI31, a proline-rich inhibitor of the proteasome J. Biol. Chem. 275 2000 18557 18565
51. D.M. Zaiss PI31 is a modulator of proteasome formation and antigen processing Proc. Natl. Acad. Sci. U. S. A. 99 2002 14344 14349
52. D.M. Zaiss The proteasome inhibitor PI31 competes with PA28 for binding to 20S proteasomes FEBS Lett. 457 1999 333 338
53. R.L. Gallo Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds Proc. Natl. Acad. Sci. U. S. A. 91 1994 11035 11039
54. Y. Gao Inhibition of ubiquitin-proteasome pathway-mediated IκBα degradation by a naturally occurring antibacterial peptide J. Clin. Invest. 106 2000 439 448
55. J. Li PR39, a peptide regulator of angiogenesis Nat. Med. 6 2000 49 55
56. M. Gaczynska Proline- and arginine-rich peptides constitute a novel class of allosteric inhibitors of proteasome activity Biochemistry 42 2003 8663 8670
57. P. Nelbock A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator Science 248 1990 1650 1653
58. M. Seeger HIV-1 tat inhibits the 20 S proteasome and its 11 S regulator-mediated activation J. Biol. Chem. 272 1997 8145 8148
59. X. Huang The RTP site shared by the HIV-1 Tat protein and the 11S regulator subunit α is crucial for their effects on proteasome function including antigen processing J. Mol. Biol. 323 2002 771 782
60. G.S. Apcher Human immunodeficiency virus-1 Tat protein interacts with distinct proteasomal α and β subunits FEBS Lett. 553 2003 200 204
61. Z. Hu Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex J. Virol. 73 1999 7231 7240
62. J. Huang Proteasome complex as a potential cellular target of hepatitis B virus X protein J. Virol. 70 1996 5582 5591
63. R. Stohwasser Hepatitis B virus HBx peptide 116-138 and proteasome activator PA28 compete for binding to the proteasome α4/MC6 subunit Biol. Chem. 384 2003 39 49
64. M. Unno The structure of the mammalian 20S proteasome at 2.75 Å resolution Structure 10 2002 609 618